Aurobindo Pharma Limited (BOM:524804)
India flag India · Delayed Price · Currency is INR
1,035.25
+0.20 (0.02%)
At close: Sep 4, 2025

Aurobindo Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212017 - 2021
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2017 - 2021
601,710674,020637,941303,575391,729516,388
Upgrade
Market Cap Growth
-6.85%5.66%110.14%-22.50%-24.14%113.31%
Upgrade
Enterprise Value
601,920689,676632,994283,996394,408532,915
Upgrade
Last Close Price
1035.251155.361085.37513.78653.74855.88
Upgrade
PE Ratio
17.7419.3420.1115.7514.799.68
Upgrade
PS Ratio
1.882.132.201.221.672.08
Upgrade
PB Ratio
1.842.072.141.131.592.36
Upgrade
P/TBV Ratio
2.122.362.461.311.852.73
Upgrade
P/FCF Ratio
-34.45--13.2227.31
Upgrade
P/OCF Ratio
-17.1726.2012.727.8115.51
Upgrade
EV/Sales Ratio
1.882.172.181.141.682.15
Upgrade
EV/EBITDA Ratio
9.0810.7210.987.819.159.88
Upgrade
EV/EBIT Ratio
12.2613.8314.4111.3111.9311.97
Upgrade
EV/FCF Ratio
-35.25--13.3128.18
Upgrade
Debt / Equity Ratio
0.250.250.220.200.120.24
Upgrade
Debt / EBITDA Ratio
1.241.271.141.430.650.97
Upgrade
Debt / FCF Ratio
-4.22--0.962.82
Upgrade
Asset Turnover
-0.670.680.670.690.79
Upgrade
Inventory Turnover
-1.331.421.451.261.22
Upgrade
Quick Ratio
-0.990.960.981.100.90
Upgrade
Current Ratio
-1.851.981.882.221.86
Upgrade
Return on Equity (ROE)
-11.15%11.18%7.50%11.39%27.53%
Upgrade
Return on Assets (ROA)
-6.57%6.46%4.25%6.10%8.87%
Upgrade
Return on Capital (ROIC)
7.98%8.05%8.00%5.27%7.56%11.13%
Upgrade
Return on Capital Employed (ROCE)
-14.20%13.40%8.80%12.80%19.20%
Upgrade
Earnings Yield
5.64%5.17%4.97%6.35%6.76%10.33%
Upgrade
FCF Yield
-2.90%-0.54%-0.06%7.56%3.66%
Upgrade
Dividend Yield
0.39%-0.41%0.58%1.38%0.47%
Upgrade
Payout Ratio
-0.03%8.31%22.80%9.96%4.39%
Upgrade
Buyback Yield / Dilution
0.74%0.52%----
Upgrade
Total Shareholder Return
1.13%0.52%0.41%0.58%1.38%0.47%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.